Factors affecting survival and prognosis in extensive stage small cell lung cancer

Factors affecting survival and prognosis in extensive stage small cell lung cancer

Abstract Although chemotherapy significantly improves the quality of life and prolongs survival in patients with extensive-stage small cell lung cancer (ES-SCLC), relapse is almost inevitable, with only 5% of patients surviving two years after the initial diagnosis. Prophylactic cranial irradiation...

Full description

Saved in:
Bibliographic Details
Main Authors: Mert Erciyestepe, Ömer Burak Ekinci, Hale Gülçin Yıldırım Doğan, Ahmet Emin Öztürk, Okan Aydın, Aslı Büyükkuşcu, Tugay Atasever, Beyza Soylu Uslu, Kübra Akkaya, Emir Çelik, Kayhan Ertürk, Muhammed Mustafa Atcı
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Pulmonary Medicine
Subjects:
Extensive Stage
Small Cell Lung Cancer
Survival and Prognosis
Online Access:https://doi.org/10.1186/s12890-025-03625-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12890-025-03625-w

Similar Items